Item 2.02. Results of Operations and Financial Condition.
On April 17, 2023, INVO Bioscience, Inc. issued a press release
announcing financial results for the period ended December 31, 2022. The. | April 17, 2023
Cedar Brook Financial Partners LLC reduced its holdings in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 4.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,588 shares of the company’s stock after selling 149 shares during the quarter. […]
Red Tortoise LLC acquired a new stake in Novo Nordisk A/S (NYSE:NVO – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 487 shares of the company’s stock, valued at approximately $66,000. Other large investors also recently […]
Cedar Brook Financial Partners LLC lowered its position in shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) by 4.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,588 shares of the company’s stock after selling 149 shares during the […]
Credit Suisse Group upgraded shares of Novo Nordisk A/S (NYSE:NVO – Get Rating) from a neutral rating to an outperform rating in a research report released on Thursday morning, The Fly reports. A number of other research analysts also recently issued reports on NVO. StockNews.com started coverage on shares of Novo Nordisk A/S in a […]